No trials match your search ""

• Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

  Stanford is currently accepting patients for this trial.

• Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

  Stanford is currently accepting patients for this trial.

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  Stanford is currently accepting patients for this trial.

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Cancer Genetics Hereditary Cancer Panel Testing

  Stanford is currently accepting patients for this trial.

• A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

  Stanford is currently accepting patients for this trial.

• Phase 2 Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

  Stanford is currently accepting patients for this trial.

• Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

  Stanford is currently accepting patients for this trial.

• A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

  Stanford is currently accepting patients for this trial.

• De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  Stanford is currently accepting patients for this trial.

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

  Stanford is currently accepting patients for this trial.

• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

  Stanford is currently accepting patients for this trial.

• A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

No trials match your search ""

• Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

  Stanford is currently accepting patients for this trial.

• Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

  Stanford is currently accepting patients for this trial.

• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  Stanford is currently accepting patients for this trial.

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

  Stanford is currently accepting patients for this trial.

• Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors

  Stanford is currently accepting patients for this trial.

• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

  Stanford is currently accepting patients for this trial.

• A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

  Stanford is currently accepting patients for this trial.

• A Study of AL102 in Patients With Progressing Desmoid Tumors

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.